Breakthrough Gives Hope to People Suffering from COPD

By Chelsey | September 21, 2018 |

FDA Approves Zephyr Endobronchial Valve for Treating COPD Emphysema In June, 2018, the Pulmonx Corporation announced that the Food and Drug Administration (FDA) approved the use of the Zephyr Endobronchial Valve for treating patients with emphysema, which is an incurable life-threatening type of chronic obstructive pulmonary disease (COPD). Zephyr Valve Trial A new lung treatment…

Read More